Search Within

Martin Henner Voss

  1. "2020"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (10)
  3. Editorial (1)
  4. Guidelines (1)
  5. Review (1)
Groups
  1. Department of Medicine (23)
  2. Genitourinary Oncology Service (23)
  3. Solid Tumor Oncology Division (23)
  4. Human Oncology and Pathogenesis Program (13)
  5. Surgery (12)
  6. Urology (12)

More Groups

People
  1. Robert Motzer (16)
  2. Abraham Hakimi (12)
  3. Chung-Han Lee (8)
  4. Maria Carlo (8)
  5. Renzo Dinatale (8)
  6. Paul Russo (7)

More People

Years
  1. 2020 (23)
Publications
  1. Journal of Clinical Oncology (9)
  2. British Journal of Cancer (2)
  3. Annals of Translational Medicine (1)
  4. BMC Urology (1)
  5. CUAJ-Canadian Urological Association Journal (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Nature Publishing Group (3)
  3. Biomed Central Ltd (2)
  4. Elsevier Science, Inc. (2)
  5. AME Publishing Company (1)
  6. American Association for Cancer Research (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; Knezevic, A.; Shah, N. J.; Carlo, M. I.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Noninvasive genomic profiling of 113 patients with advanced renal cell carcinoma
    Meeting Abstract

    Gedvilaite, E.; Kotecha, R.; Murray, S.; Foster, A.; Motzer, R.; Ptashkin, R.; Johnson, I.; Shah, R.; Dunigan, M.; Huberman, K.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Prognostic models in papillary renal cell carcinoma
    Editorial

    Attalla, K.; Voss, M. H.; Hakimi, A. A.
    Annals of Translational Medicine (2020)

    Fulltext@MSK | Save
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer
    Journal Article

    Voss, M. H.; Gordon, M. S.; Mita, M.; Rini, B.; Makker, V.; Macarulla, T.; Smith, D. C.; Cervantes, A.; Puzanov, I.; Pili, R.; more...
    British Journal of Cancer (2020)

    Fulltext@MSK | Save
  • First-in-humans trial of dasatinib-derivative tracer for tumor kinase-targeted PET
    Journal Article

    Krebs, S.; Veach, D. R.; Carter, L. M.; Grkovski, M.; Fornier, M.; Mauro, M. J.; Voss, M. H.; Danila, D. C.; Burnazi, E.; Null, M.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC)
    Meeting Abstract

    Voss, M. H.; Hotson, A. N.; Willingham, S.; Hughes, B. G. M.; Merchan, J. R.; Fong, L.; Chu, M.; George, S.; Munneke, B.; Mobasher, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT)
    Meeting Abstract

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Silagy, A. W.; Marker, M.; Reising, A.; Millholland, J.; Chan, T. A. T.; Russo, P.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Axitinib plus immune checkpoint inhibitor: Evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events
    Guidelines

    Grünwald, V.; Voss, M. H.; Rini, B. I.; Powles, T.; Albiges, L.; Giles, R. H.; Jonasch, E.
    British Journal of Cancer (2020)

    Fulltext@MSK | Save
  • An evaluation of the role of tumor load in cytoreductive nephrectomy
    Journal Article

    Silagy, A. W.; Duzgol, C.; Marcon, J.; DiNatale, R. G.; Mano, R.; Blum, K. A.; Reznik, E.; Voss, M. H.; Motzer, R. J.; Coleman, J. A.; more...
    CUAJ-Canadian Urological Association Journal (2020)

    Fulltext@MSK | Save